Bessemer Group Inc Pds Biotechnology Corp Transaction History
Bessemer Group Inc
- $61.3 Billion
- Q4 2024
A detailed history of Bessemer Group Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Bessemer Group Inc holds 1,146 shares of PDSB stock, worth $1,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,146Holding current value
$1,627% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
59Shares Held
4.22MCall Options Held
170KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$691,4930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$592,4480.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$350,7070.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$312,7050.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $40.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...